Phathom Pharmaceuticals (PHAT) Other Working Capital Changes (2022 - 2026)
Phathom Pharmaceuticals (PHAT) has disclosed Other Working Capital Changes for 5 consecutive years, with -$6.9 million as the latest value for Q1 2026.
- For Q1 2026, Other Working Capital Changes rose 11.42% year-over-year to -$6.9 million; the TTM value through Mar 2026 reached -$4.6 million, down 1595.47%, while the annual FY2025 figure was -$5.5 million, 171.86% down from the prior year.
- Other Working Capital Changes hit -$6.9 million in Q1 2026 for Phathom Pharmaceuticals, down from $2.1 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $5.9 million in Q4 2024 and bottomed at -$7.8 million in Q1 2025.
- Average Other Working Capital Changes over 5 years is $304000.0, with a median of $254000.0 recorded in 2023.
- Year-over-year, Other Working Capital Changes soared 2218.11% in 2024 and then crashed 1647.2% in 2025.
- Phathom Pharmaceuticals' Other Working Capital Changes stood at $4.2 million in 2022, then plummeted by 93.88% to $254000.0 in 2023, then skyrocketed by 2218.11% to $5.9 million in 2024, then tumbled by 63.91% to $2.1 million in 2025, then plummeted by 425.55% to -$6.9 million in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$6.9 million, $2.1 million, and -$1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.